You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SLL

Showing 1 - 25 of 503
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)

Not yet recruiting
  • CLL/SLL
  • lisaftoclax +BTK inhibitor
  • BTK inhibitor
  • (no location specified)
Oct 26, 2023

CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)

Not yet recruiting
  • CLL/SLL
  • Orelabrutinib and BG
  • Wuhan, Hubei, China
  • +1 more
Jun 15, 2023

Orelabrutinib in the Treatment of CLL/SLL

Not yet recruiting
  • CLL/SLL
    • (no location specified)
    Jul 26, 2023

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • 5:2 Method (intermittent fasting regimen)
    • 16/8 Method (intermittent fast regimen)
    • Victoria, British Columbia, Canada
      Eleah Stringer
    Feb 2, 2023

    CLL/SLL Trial in Beijing (orelabrutinib)

    Recruiting
    • CLL/SLL
    • Beijing, Beijing, China
    • +1 more
    Aug 5, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • TQB3909 tablet
    • Zhengzhou, Henan, China
    • +1 more
    Jul 17, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Acalabrutinib (Arm A)
    • Acalabrutinib (Arm B)
    • Bethesda, Maryland
      Research Site
    Jan 3, 2023

    Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

    Recruiting
    • Relapsed or Refractory CD19+ B-cell Lymphoma
    • +2 more
    • TBI-2001
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jul 26, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +5 more
    • (no location specified)
    Jul 21, 2023

    Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

    Completed
    • Lymphoid Leukemia
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin
    Jan 30, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • High Dose Methylprednisolone (HDMP)
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 12, 2023

    Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)

    Active, not recruiting
    • Leukemia
    • Lymphoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Oct 11, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL) Trial in United States (Zanubrutinib, Obinutuzumab,

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Leukemia (SLL)
    • Evanston, Illinois
    • +7 more
    Sep 9, 2022

    Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)

    Terminated
    Has Results
    • Chronic Lymphocytic Leukemia(CLL)
    • Small Lymphocytic Lymphoma
    • Hackensack, New Jersey
      Hackensack University Medical Center
    Jun 24, 2022

    Orelabrutinib in Treatment of Chronic Lymphocytic Leukemia/Small

    Recruiting
    • CLL/SLL
    • Jinan, Shandong, China
      Department of Hematology, Shandong Provincial Hospital Affiliate
    Jun 16, 2023

    CLL/SLL, NHL Trial in China (BN102)

    Not yet recruiting
    • CLL/SLL
    • NHL
    • Guangzhou, China
    • +5 more
    May 4, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Houston (Paclitaxel, Carboplatin, Bevacizumab)

    Recruiting
    • Ovarian Cancer
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Feb 13, 2023

    Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Chicago, Rochester, Cleveland (Venetoclax, Umbralisib, Ublituximab)

    Terminated
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Chicago, Illinois
    • +2 more
    Aug 19, 2022

    CLL/SLL, NHL, MCL Trial in United States (HMPL-760)

    Recruiting
    • CLL/SLL
    • +8 more
    • Atlanta, Georgia
    • +3 more
    Feb 24, 2022

    Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)

    Terminated
    Has Results
    • Small Lymphocytic Leukemia (SLL)
    • Chronic Lymphocytic Leukemia (CLL)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 15, 2022

    Leukemia, Lymphoma Trial in Houston (Ofatumumab)

    Active, not recruiting
    • Leukemia
    • Lymphoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 9, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Zanubrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma
    • Boston, Massachusetts
    • +2 more
    Mar 16, 2022

    Tumors, Leukemia, Lymphocytic, Chronic, Lymphoma, Small Lymphocytic Trial in Victoria (Intermittent fast)

    Active, not recruiting
    • Neoplasms
    • +5 more
    • Intermittent fast
    • Victoria, British Columbia, Canada
      Eleah Stringer
    Mar 15, 2022

    Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Feb 23, 2022

    CLL, SLL, HCL Trial in Dresden

    Recruiting
    • CLL
    • +7 more
      • Dresden, Sachsen, Germany
        BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
      Apr 29, 2022